Insider trade

Mineralys Therapeutics (MLYS)CEO sold ~$187K

Jon Congleton, CEO at Mineralys Therapeutics, sold ~$187K of Mineralys Therapeutics shares.

~$187K
Approx. value · 15K sh @ $12.19: 862K
Holds after · shares reported

Traded: Apr 11, 2025
Filed: Apr 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Mar 13, 2025Insider · 4 peopleInsiders: 4 purchases (~$37.2M)
Apr 1, 2025Insider · 1 personInsiders: 3 sales (~$879K)
Apr 11, 2025 · this disclosureInsiderCEO sold ~$187K of MLYS shares in the open market

What came next

Apr 11, 2025InsiderCFO sold ~$130K of MLYS shares in the open market
Apr 14, 2025Insider · 1 personInsiders: 2 sales (~$165K)
May 14, 2025InsiderOfficer sold ~$174K of MLYS shares in the open market
Jun 13, 2025InsiderOfficer sold ~$166K of MLYS shares in the open market
Jul 11, 2025Insider · 2 peopleInsiders: 2 sales (~$386K)
Jul 14, 2025InsiderOfficer sold ~$166K of MLYS shares in the open market
Jul 28, 2025InsiderCFO sold ~$182K of MLYS shares in the open market
Jul 29, 2025InsiderCFO sold ~$11K of MLYS shares in the open market
Jul 30, 2025Insider · 1 personInsiders: 2 sales (~$884K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Mineralys Therapeutics

For Mineralys Therapeutics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MLYS page.

Other recent filings by Jon Congleton, Chief Executive Officer

The full history of Jon Congleton, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Mineralys Therapeutics

Everything OQRO holds on this company is on its MLYS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data